亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis

红斑 医学 皮疹 皮肤病科 水肿 特应性皮炎 外科
作者
Teppei Hagino,Mai Yoshida,Risa Hamada,Eita Fujimoto,Hidehisa Saeki,Naoko Kanda
出处
期刊:Journal of Dermatology [Wiley]
卷期号:50 (12): 1576-1584 被引量:10
标识
DOI:10.1111/1346-8138.16950
摘要

Atopic dermatitis (AD) is a chronic eczematous disease with various types of rash, erythema, edema/papulation, excoriation, or lichenification. Janus kinase 1 inhibitor upadacitinib is effective for moderate-to-severe AD. We aimed to investigate the therapeutic effects of upadacitinib on each rash type in AD patients in real-world clinical practice. Seventy-two Japanese patients with moderate-to-severe AD were treated with oral upadacitinib 15 mg/day plus topical corticosteroids. The Eczema Area and Severity Index (EASI) scores for erythema, edema/papulation, excoriation, or lichenification on the whole body or on head and neck, upper limbs, lower limbs, or trunk were assessed at weeks 0, 4, and 12 of treatment. The proportions of patients who achieved resolution or at least 75% reduction of EASI from baseline (EASI 75) for individual rash types were calculated at weeks 4 and 12 on the whole body or each anatomical site. The resolution rates for excoriation, erythema, edema/papulation, or lichenification on the whole body were 38.3%, 23.7%, 21.7%, and 8.3% at week 4 and 18.3%, 18.6%, 11.6%, and 13.3% at week 12, respectively. The EASI scores for all rash types significantly decreased at weeks 4 and 12 compared to week 0. The achievement rates of EASI 75 for excoriation, erythema, edema/papulation, or lichenification on the whole body were 67.2%, 66.7%, 49.2%, and 37.7% at week 4 and 57.3%, 65%, 41%, and 41% at week 12, respectively. The achievement rate of EASI 75 for erythema on head and neck at week 4 (45.3%) was lower than that on upper limbs (71%) and on lower limbs (70.8%), and that on head and neck at week 12 (42.2%) was lower than that on lower limbs (69.2%). These results indicate that upadacitinib is effective for all AD rash types, especially for excoriation and erythema, while head-and-neck erythema might be less responsive to upadacitinib.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xie完成签到 ,获得积分10
1秒前
zzz完成签到,获得积分10
8秒前
9秒前
刘明坤完成签到 ,获得积分10
9秒前
11秒前
11秒前
zhoux发布了新的文献求助10
12秒前
14秒前
上官若男应助ceeray23采纳,获得20
14秒前
研友_qZ6V1Z发布了新的文献求助10
16秒前
18秒前
星辰大海应助towerman采纳,获得10
20秒前
xutong de完成签到,获得积分10
23秒前
qpp完成签到,获得积分10
24秒前
三木足球完成签到,获得积分10
25秒前
zhoux完成签到,获得积分10
28秒前
coc完成签到,获得积分10
33秒前
33秒前
35秒前
35秒前
towerman发布了新的文献求助10
38秒前
上官若男应助研友_qZ6V1Z采纳,获得10
42秒前
FengyaoWang完成签到,获得积分10
42秒前
43秒前
enchanted发布了新的文献求助10
48秒前
ZHANG123完成签到,获得积分10
52秒前
59秒前
七色光完成签到,获得积分10
1分钟前
1分钟前
1分钟前
ceeray23发布了新的文献求助20
1分钟前
爆米花应助Bowman采纳,获得30
1分钟前
1分钟前
研友_qZ6V1Z发布了新的文献求助10
1分钟前
1分钟前
shaylie完成签到 ,获得积分10
1分钟前
伽拉发布了新的文献求助10
1分钟前
轻松的惜芹应助linkman采纳,获得10
1分钟前
Karol发布了新的文献求助10
1分钟前
1分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990012
求助须知:如何正确求助?哪些是违规求助? 3532049
关于积分的说明 11256153
捐赠科研通 3270925
什么是DOI,文献DOI怎么找? 1805123
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809216